查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
荷爾蒙替代療法市場，按療法、按給藥途徑、按適應症、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1351414

荷爾蒙替代療法市場，按療法、按給藥途徑、按適應症、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Hormone Replacement Therapy Market, By Therapy, By Route of Administration, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年荷爾蒙替代療法市場規模為2098,032萬美元，2023年至2030年年複合成長率為6.2%。

HRT 提供一系列給藥方案，包括口服藥片、貼片、外用乳膏和注射劑型。儘管如此，接受荷爾蒙替代療法的決定需要對潛在風險和益處進行徹底評估。個人必須與醫療保健專業人員進行全面討論，以便就其治療過程做出明智且個性化的選擇。

荷爾蒙替代療法市場 - 市場動態：

  • 緩解更年期症狀、提高女性生活品質的願望推動市場需求
  • 更年期相關不適的影響包括潮熱、情緒波動和骨骼健康問題等，可能會嚴重干擾日常生活。荷爾蒙替代療法（HRT）成為一種有價值的解決方案，透過恢復荷爾蒙水平、減輕症狀和緩解相關不適來應對這些挑戰。這促使許多女性將荷爾蒙替代療法視為在人生過渡階段恢復舒適和整體健康的一種手段。對女性健康賦權的日益重視，加上對荷爾蒙替代療法潛在益處的認知不斷增強，有助於這種療法的持續流行。

荷爾蒙替代療法市場 - 主要見解：

  • 全球荷爾蒙替代療法市場根據療法、給藥途徑和地區進行分類。
  • 該市場根據治療方法分為多種類別，包括雌激素替代品、生長激素替代品、甲狀腺激素替代品和睪固酮激素替代品。其中，雌激素替代品在 2022 年佔據最大的市場佔有率。
  • 就給藥途徑而言，市場分為口服、腸外和經皮給藥。腸外給藥是 2022 年的主要給藥途徑。
  • 就地區而言，亞太地區將成為 2022 年主要的收入來源。

荷爾蒙替代療法市場-細分分析：

  • 全球荷爾蒙替代療法市場根據療法、給藥途徑、適應症和地區進行細分。
  • 該市場由各種治療類別組成，包括雌激素替代品、生長激素替代品、甲狀腺激素替代品和睪固酮替代品。其中，雌激素替代品率先佔領市場。雌激素替代療法 (HRT) 因其在解決潮熱、陰道乾燥和骨骼健康問題等更年期症狀方面的有效性而持續受歡迎。女性擴大轉向雌激素 HRT 來提高更年期過渡期間的整體生活品質，這使其作為首選治療選擇的持續突出。

荷爾蒙替代療法市場-競爭格局：

目前，荷爾蒙替代療法（HRT）的競爭格局由諾華、輝瑞、禮來等主要製藥巨頭佔據主導地位。這些行業領導者利用其廣泛的研究能力和良好的品牌知名度，提供一系列荷爾蒙產品，同時享有廣泛的市場佔有率。

此外，該市場還包括 TherapeuticsMD 和 Mithra Pharmaceuticals 等規模較小的專業公司，它們專注於開發利基配方以滿足特定的醫療保健需求。 HRT 市場內的競爭受到治療效果、安全性考量、給藥方法和病患偏好等因素的影響。預計對個人化醫療保健解決方案的需求不斷成長，優先開發創新、耐受性良好且方便用戶使用的 HRT 方案的公司可能會在這個不斷發展的市場中獲得競爭優勢。

目錄

第一章：荷爾蒙替代療法市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 荷爾蒙替代療法市場片段（按療法）
    • 依給藥途徑分類的荷爾蒙替代療法市場片段
    • 按適應症分類的荷爾蒙替代療法市場片段
    • 按國家/地區分類的荷爾蒙替代療法市場片段
    • 按地區分類的荷爾蒙替代療法市場片段
  • 競爭洞察

第 3 章：荷爾蒙替代療法主要市場趨勢

  • 荷爾蒙替代療法市場促進因素
    • 市場促進因素的影響分析
  • 荷爾蒙替代療法市場限制
    • 市場限制影響分析
  • 荷爾蒙替代療法的市場機會
  • 荷爾蒙替代療法市場未來趨勢

第 4 章：荷爾蒙替代療法產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：荷爾蒙替代療法市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：荷爾蒙替代療法市場格局

  • 2022 年荷爾蒙替代療法市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：荷爾蒙替代療法市場 - 按療法

  • 概述
    • 按療法分類的細分市場佔有率分析
    • 雌激素替代品
    • 生長激素替代品
    • 甲狀腺激素替代療法
    • 睾酮替代品

第 8 章：荷爾蒙替代療法市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市佔率分析
    • 口服
    • 注射用
    • 其他給藥途徑

第 9 章：荷爾蒙替代療法市場 - 按適應症

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 停經
    • 甲狀腺功能低下症
    • 生長激素缺乏
    • 其他適應症

第 10 章：荷爾蒙替代療法市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美荷爾蒙替代療法主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按治療）
    • 北美市場規模與預測（按管理途徑）
    • 北美市場規模和預測（按指標）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲荷爾蒙替代療法主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按治療）
    • 歐洲市場規模與預測（按管理途徑）
    • 歐洲市場規模與預測（按指標）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區荷爾蒙替代療法主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按治療）
    • 亞太地區市場規模與預測（依管理途徑）
    • 亞太地區市場規模與預測（依指標）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲荷爾蒙替代療法主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按療法）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 拉丁美洲市場規模與預測（按指標）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲激素替代療法主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模和預測（按療法）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模及預測（依指標）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 荷爾蒙替代療法產業

  • 競爭儀表板
  • 公司簡介
    • Novartis Pharmaceuticals
    • Pfizer Inc.
    • Eli Lilly and Company
    • Bayer AG
    • AbbVie Inc.
    • Merck & Co., Inc.
    • Amgen Inc.
    • TherapeuticsMD, Inc.
    • Allergan plc
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals
    • Mithra Pharmaceuticals
    • Noven Pharmaceuticals
    • Besins Healthcare

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1662

REPORT HIGHLIGHT

Hormone Replacement Therapy Market size was valued at USD 20,980.32 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.

Hormone Replacement Therapy (HRT) is a medical intervention aimed at restoring hormonal equilibrium in individuals experiencing hormonal deficiencies or imbalances. This therapy can involve the use of synthetic or naturally occurring hormones, such as estrogen, progesterone, or a combination of both. It is commonly employed to alleviate symptoms associated with menopause or specific medical conditions. The primary objective of HRT is to mitigate discomforting symptoms like hot flashes, mood swings, and the loss of bone density.

HRT offers a range of administration options, including oral tablets, patches, topical creams, and injectable formulations. Nonetheless, the decision to undergo HRT necessitates a thorough evaluation of potential risks and benefits. It is essential for individuals to engage in comprehensive discussions with healthcare professionals to make well-informed and personalized choices regarding their treatment journey.

Hormone Replacement Therapy Market - Market Dynamics:

  • Desire to alleviate menopausal symptoms and enhance quality of life for women to propel market demand
  • The impact of menopause-related discomforts, which can encompass issues like hot flashes, mood swings, and bone health concerns, can significantly disrupt daily life. Hormone Replacement Therapy (HRT) emerges as a valuable solution for addressing these challenges by restoring hormone levels, reducing symptoms, and easing associated discomfort. This prompts many women to consider HRT as a means of regaining comfort and overall well-being during this transitional phase of life. The increasing emphasis on women's health empowerment, coupled with a growing awareness of the potential benefits of HRT, contributes to the sustained popularity of this therapy.

Hormone Replacement Therapy Market - Key Insights:

  • The Global Hormone Replacement Therapy Market is categorized based on Therapy, Route of Administration, and Region.
  • This market is divided into various categories depending on Therapy, including Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, and Testosterone Hormone Replacement. Among these, Estrogen Hormone Replacement held the largest market share in 2022.
  • In terms of Route of Administration, the market is segmented into Oral, Parenteral, and Transdermal. Parenteral was the leading route of administration in 2022.
  • When it comes to regions, Asia Pacific emerged as the leading revenue generator in 2022.

Hormone Replacement Therapy Market- Segmentation Analysis:

  • The Global Hormone Replacement Therapy Market is segmented based on Therapy, Route of Administration, Indication, and Region.
  • The market consists of various Therapy categories, including Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, and Testosterone Replacement. Among these categories, Estrogen Hormone Replacement takes the lead in dominating the market. The popularity of Estrogen Hormone Replacement Therapy (HRT) persists due to its effectiveness in addressing menopausal symptoms like hot flashes, vaginal dryness, and bone health concerns. Women increasingly turn to Estrogen HRT to enhance their overall quality of life during the menopausal transition, contributing to its sustained prominence as a preferred therapeutic option.

Hormone Replacement Therapy Market- Competitive Landscape:

The competitive landscape of Hormone Replacement Therapy (HRT) is currently marked by the dominance of major pharmaceutical giants like Novartis, Pfizer, and Eli Lilly. These industry leaders leverage their extensive research capabilities and well-established brand recognition to offer a range of hormone products while enjoying a wide market presence.

Moreover, the market includes smaller, specialized companies such as TherapeuticsMD and Mithra Pharmaceuticals, which focus on developing niche formulations to cater to specific healthcare needs. Competition within the HRT market is influenced by factors like treatment effectiveness, safety considerations, administration methods, and patient preferences. In anticipation of the growing demand for personalized healthcare solutions, companies that prioritize the development of innovative, well-tolerated, and user-friendly HRT options are likely to gain a competitive edge in this evolving market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HORMONE REPLACEMENT THERAPY MARKET KEY PLAYERS

  • Novartis Pharmaceuticals
  • Pfizer Inc.
  • Eli Lilly and Company
  • Bayer AG
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Amgen Inc.
  • TherapeuticsMD, Inc.
  • Allergan plc
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Glenmark Pharmaceuticals
  • Mithra Pharmaceuticals
  • Noven Pharmaceuticals
  • Besins Healthcare

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY

  • Estrogen Hormone Replacement
  • Growth Hormone Replacement
  • Thyroid Hormone Replacement
  • Testosterone Replacement

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Parenteral
  • Other Routes of Administration

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION

  • Menopause
  • Hypothyroidism
  • Growth Hormone Deficiency
  • Other Indications

GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Hormone Replacement Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hormone Replacement Therapy Market Snippet by Therapy
    • 2.1.2. Hormone Replacement Therapy Market Snippet by Route of Administration
    • 2.1.3. Hormone Replacement Therapy Market Snippet by Indication
    • 2.1.4. Hormone Replacement Therapy Market Snippet by Country
    • 2.1.5. Hormone Replacement Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Hormone Replacement Therapy Key Market Trends

  • 3.1. Hormone Replacement Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hormone Replacement Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hormone Replacement Therapy Market Opportunities
  • 3.4. Hormone Replacement Therapy Market Future Trends

4. Hormone Replacement Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hormone Replacement Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hormone Replacement Therapy Market Landscape

  • 6.1. Hormone Replacement Therapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hormone Replacement Therapy Market - By Therapy

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy, 2022 & 2030 (%)
    • 7.1.2. Estrogen Hormone Replacement
    • 7.1.3. Growth Hormone Replacement
    • 7.1.4. Thyroid Hormone Replacement
    • 7.1.5. Testosterone Replacement

8. Hormone Replacement Therapy Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Parenteral
    • 8.1.4. Other Routes of Administration

9. Hormone Replacement Therapy Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 9.1.2. Menopause
    • 9.1.3. Hypothyroidism
    • 9.1.4. Growth Hormone Deficiency
    • 9.1.5. Other Indications

10. Hormone Replacement Therapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hormone Replacement Therapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hormone Replacement Therapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hormone Replacement Therapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Hormone Replacement Therapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Hormone Replacement Therapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Hormone Replacement Therapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Novartis Pharmaceuticals
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Eli Lilly and Company
    • 11.2.4. Bayer AG
    • 11.2.5. AbbVie Inc.
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Amgen Inc.
    • 11.2.8. TherapeuticsMD, Inc.
    • 11.2.9. Allergan plc
    • 11.2.10. Mylan N.V.
    • 11.2.11. Teva Pharmaceutical Industries Ltd.
    • 11.2.12. Glenmark Pharmaceuticals
    • 11.2.13. Mithra Pharmaceuticals
    • 11.2.14. Noven Pharmaceuticals
    • 11.2.15. Besins Healthcare

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hormone Replacement Therapy Market: Therapy Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy
  • TABLE Global Hormone Replacement Therapy Market, by Therapy 2018-2030 (USD Million)
  • TABLE Hormone Replacement Therapy Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Hormone Replacement Therapy Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Hormone Replacement Therapy Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Hormone Replacement Therapy Market, by Indication 2018-2030 (USD Million)
  • TABLE Hormone Replacement Therapy Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hormone Replacement Therapy Market, by Region 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hormone Replacement Therapy Market, by Indication, 2018-2030 (USD Million)